Search
Menu
Home
HTB
2002
September
September 2002
Contents
On the web
‘Natural’ resistance to HIV: is the evidence good enough to design an effective vaccine?
Insights into HIV-specific CD4+ T cell immunity
Cytomegalovirus: update
The switching spiral: a triumph of hope over benefit?
Peripheral neuropathy
The push for once-daily HAART: a call for caution
Enhancing adherence to antiretrovirals: strategies and regimens
High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia
HAART and prevention of HIV transmission
PDFs
Volume 3 Number 7 August/September 2002 PDF
Post navigation
Newer articles
HTB RSS
Early access
UK guidelines on doxyPEP to prevent syphilis
17 June 2025
APBI calls for greater participant diversity in industry studiesĀ
15 June 2025
TAG challenges HIV vaccine cuts as Robert F. Kennedy fires entire CDC vaccine expert advisory panel
6 June 2025
Gates Foundation commits to providing lenacapavir as PrEP next year
3 June 2025
All early access reports
Current issues
June 2025
May 2025
April 2025
Back issues
Special report
APBI calls for greater participant diversity in industry studiesĀ
15 June 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate